Photo of Kevin Erb

Kevin’s practice involves guiding clients through the complexities of federal, state, local and international taxation.

Kevin routinely advises business entities, tax-exempt organizations and high net worth individuals on a range of transactional tax matters. He provides tax counsel for business entity formation, mergers, acquisitions and reorganizations.

Kevin also represents clients before the IRS and state tax authorities, preparing IRS protests and appeals and assisting clients facing tax penalties.

For tax-exempt organizations, Kevin partners with clients to secure and maintain tax status and prepares Form 1023 and state-law counterparts.

During the COVID-19 pandemic, Kevin advised clients on international, state and local tax considerations arising from work-from-home arrangements. He continues to assist clients with the evolving post-COVID tax landscape.

Prior to entering private law practice, Kevin served as a tax consultant with a Big Four accounting firm, focusing on state and local taxation.

On October 14, 2022, President Joe Biden signed Executive Order 14036, directing the Department of Health and Human Services (“HHS”) to consider innovative actions to drive down certain single-source prescription drug costs as the Biden-Harris Administration works to implement the Inflation Reduction Act of 2022 (the “Act”).